猴痘。

Monkeypox.

机构信息

Skin Neglected Tropical Diseases and Sexually Transmitted Infections section, Hospital Universitari Germans Trías i Pujol, Badalona, Spain; Fight Infectious Diseases Foundation, Badalona, Spain; School of Medicine and Health Sciences, University of Papua New Guinea, Port Moresby, Papua New Guinea.

Department of Internal Medicine, Infectious Diseases Unit, Niger Delta University and Niger Delta University Teaching Hospital, Bayelsa, Nigeria.

出版信息

Lancet. 2023 Jan 7;401(10370):60-74. doi: 10.1016/S0140-6736(22)02075-X. Epub 2022 Nov 17.

Abstract

Monkeypox is a zoonotic illness caused by the monkeypox virus, an Orthopoxvirus in the same genus as the variola, vaccinia, and cowpox viruses. Since the detection of the first human case in the Democratic Republic of the Congo in 1970, the disease has caused sporadic infections and outbreaks, mainly restricted to some countries in west and central Africa. In July, 2022, WHO declared monkeypox a Public Health Emergency of International Concern, on account of the unprecedented global spread of the disease outside previously endemic countries in Africa and the need for global solidarity to address this previously neglected disease. The 2022 outbreak has been primarily associated with close intimate contact (including sexual activity) and most cases have been diagnosed among men who have sex with men, who often present with novel epidemiological and clinical characteristics. In the 2022 outbreak, the incubation period ranges from 7 days to 10 days and most patients present with a systemic illness that includes fever and myalgia and a characteristic rash, with papules that evolve to vesicles, pustules, and crusts in the genital, anal, or oral regions and often involve the mucosa. Complications that require medical treatment (eg, antiviral therapy, antibacterials, and pain control) occur in up to 40% of patients and include rectal pain, odynophagia, penile oedema, and skin and anorectal abscesses. Most patients have a self-limited illness; between 1% and 13% require hospital admission (for treatment or isolation), and the case-fatality rate is less than 0·1%. A diagnosis can be made through the presence of Orthopoxvirus DNA in PCRs from lesion swabs or body fluids. Patients with severe manifestations and people at risk of severe disease (eg, immunosuppressed people) could benefit from antiviral treatment (eg, tecovirimat). The current strategy for post-exposure prophylaxis or pre-exposure prophylaxis for people at high risk is vaccination with the non-replicating modified vaccinia Ankara. Antiviral treatment and vaccines are not yet available in endemic countries in Africa.

摘要

猴痘是一种由猴痘病毒引起的人畜共患病,猴痘病毒属于正痘病毒属,与天花病毒、牛痘病毒和牛痘病毒属于同一属。自 1970 年在刚果民主共和国首次发现人类病例以来,该病已导致散发性感染和暴发,主要局限于一些西非和中非国家。2022 年 7 月,世卫组织宣布猴痘为国际关注的突发公共卫生事件,原因是该疾病在非洲以往流行国家以外的地区空前广泛传播,需要全球团结起来应对这一以前被忽视的疾病。2022 年的疫情主要与密切的亲密接触(包括性行为)有关,大多数病例发生在与男性发生性关系的男性中,他们通常具有新的流行病学和临床特征。在 2022 年的疫情中,潜伏期为 7 至 10 天,大多数患者出现全身性疾病,包括发热和肌痛以及特征性皮疹,生殖器、肛门或口腔区域的丘疹演变为水疱、脓疱和结痂,通常累及粘膜。需要治疗的并发症(例如抗病毒治疗、抗生素和止痛治疗)发生在多达 40%的患者中,包括直肠疼痛、咽痛、阴茎水肿以及皮肤和肛门直肠脓肿。大多数患者的疾病具有自限性;1%至 13%需要住院治疗(治疗或隔离),病死率低于 0.1%。通过从病变拭子或体液中的 PCR 检测到正痘病毒 DNA 可做出诊断。有严重表现和有患严重疾病风险的人(例如免疫抑制者)可以从抗病毒治疗(例如特考韦瑞玛)中获益。目前,针对高危人群的暴露后预防或暴露前预防策略是使用非复制的改良安卡拉痘苗进行接种。在非洲流行国家,抗病毒治疗和疫苗尚不可用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b6/9671644/f126e097467b/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索